OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 28, 2020
Merck will acquire Themis Bioscience and collaborate with IAVI and Ridgeback Bio on COVID-19 vaccines and therapies.
CordenPharma and Moderna extended a strategic manufacturing services agreement for the supply of lipid excipients to be used in Moderna’s vaccine against SARS-CoV-2.
May 19, 2020
HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.
Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.
May 15, 2020
As a result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes.
Single-use processing requires instruments providing the accuracy of traditional technologies but configured in form factors designed specifically for this service
May 02, 2020
Will moving at “warp speed” to develop a vaccine impact efficacy or safety?
Equipment and process optimization must be considered for scaling up these developmental technologies to commercial production.
Many antibody-drug conjugate therapies are in the pipeline; however, only a handful have been approved. What are the bottlenecks?
Reformulation strategies can provide drug developers with a head start to achieve promising options that benefit the patient.